chemical compound
Nicotinamide riboside
/ˌnɪkəˈtɪnəmaɪd ˈraɪbəsaɪd/
Also known as: NR, Niagen, Vitamin B3 derivative, Nicotinamide-beta-riboside
Overview
Nicotinamide riboside (NR) is a naturally occurring form of vitamin B3 that functions as a precursor to nicotinamide adenine dinucleotide (NAD+), a vital coenzyme involved in cellular energy production and mitochondrial health.
Found in trace amounts in milk and yeast, nicotinamide riboside is primarily manufactured and consumed as a dietary supplement. At the cellular level, NR is metabolized through the nicotinamide riboside kinase (NRK) pathway to produce NAD+. This coenzyme is indispensable for life, playing a central role in metabolic processes, DNA repair, and the regulation of cellular stress responses.
As humans age, systemic levels of NAD+ naturally decline. This depletion is closely associated with mitochondrial dysfunction and is believed to be a contributing factor to the physiological decline seen in aging and various age-related pathologies. By supplementing with NR, researchers aim to replenish cellular NAD+ pools, thereby restoring mitochondrial efficiency and enhancing cellular resilience against metabolic and oxidative stress.
Context
In the broader landscape of medical research, NR is categorized among "NAD+ boosters," alongside compounds like nicotinamide mononucleotide (NMN). Its therapeutic potential is being actively explored in neurology, cardiology, and endocrinology. Notably, NR is the investigational intervention in the NOPARK trial, a major clinical study targeting Parkinson's disease. Because Parkinson's is characterized by the progressive impairment of mitochondria within dopamine-producing neurons, NR is being tested for its ability to rescue mitochondrial function, potentially slowing or halting the neurodegenerative process.
Significance
For patients and the general public, nicotinamide riboside represents a promising intersection between nutritional supplementation and targeted pharmacology. While currently available over-the-counter as an "anti-aging" wellness supplement, its true medical significance hinges on ongoing rigorous clinical trials. If studies like NOPARK demonstrate definitive neuroprotective effects, NR could transition from a general supplement to a disease-modifying therapy, offering a novel approach to treating incurable neurodegenerative conditions by addressing their underlying cellular mechanisms.